The TiTKI Project - evaluation of the risk of thrombosis associated with the use of tyrosine kinase inhibitors

Project: Research

Project Details

StatusActive
Effective start/end date1/09/15 → …
View all
View less

Research Output

Long-Term Survival, Vascular Occlusive Events and Efficacy Biomarkers of First-Line Treatment of CML: A Meta-Analysis

Haguet, H., Graux, C., Mullier, F., Dogné, J-M. & Douxfils, J., 15 May 2020, In : Cancers. 12, 5, 15 p., 1242.

Research output: Contribution to journal › Article

File

    • An updated meta-analysis of the risks of arterial and venous occlusive events with new generation BCR-ABL TKIs in patients with chronic myeloid leukemia

    Haguet, H., Mullier, F., Graux, C., Dogne, J-M. & Douxfils, J., 13 Jun 2019.

    Research output: Contribution to conference › Poster

    In vitro investigations of the effect of BCR-ABL Tyrosine Kinase Inhibitors on endothelial cell viability

    Haguet, H., Graux, C., Dogne, J-M., Mullier, F. & Douxfils, J., Jan 2019.

    Research output: Contribution to conference › Poster

    Activities

    • 6 Oral presentation
    • 1 Invited talk

    The Namur Thrombosis and Hemostasis Center A gathering of experts from laboratory, clinical and regulatory field

    Jonathan Douxfils (Invited speaker)

    19 Mar 2019

    Activity: Talk or presentation types › Invited talk

    Mécanismes thrombotiques des inhibiteurs de tyrosine kinase ciblant BCR-ABL

    Hélène Haguet (Speaker), , Jonathan Douxfils (Speaker), , François Mullier (Speaker), , Christian Chatelain (Speaker), , Carlos Graux (Speaker), & Jean-Michel Dogne (Speaker)

    21 Mar 2019

    Activity: Talk or presentation types › Oral presentation

    In vitro effects of BCR-ABL TKIs on endothelial cell survival and functions

    Hélène Haguet (Speaker), , Jonathan Douxfils (Speaker), , Christian Chatelain (Speaker), , Carlos Graux (Speaker), , François Mullier (Speaker), & Jean-Michel Dogne (Speaker)

    9 Feb 2018

    Activity: Talk or presentation types › Oral presentation

    Prizes

    Prix Léo Pharma Cancer & Thrombosis

    Haguet, Helene (Recipient), DOUXFILS, JONATHAN (Recipient), MULLIER, Francois (Recipient) & DOGNE, Jean-Michel (Recipient), 25 Feb 2017

    Prize: Prize (including medals and awards)

    Press / Media

    Vascular Occlusion Risk Reviewed For CML New-Generation TKIs

    Jonathan Douxfils

    17/02/16

    1 item of Media coverage

    Press/Media: Expert Comment

    BCR-ABL TKIs May Increase Cardiovascular Risk

    Jonathan Douxfils

    16/02/16

    1 item of Media coverage

    Press/Media: Expert Comment

    BCR-ABL Tyrosine Kinase Inhibitors May Increase Cardiovascular Events in Chronic Myeloid Leukemia

    Jonathan Douxfils

    16/02/16

    1 item of Media coverage

    Press/Media: Expert Comment